ARRY
Barclays’s Array Biopharma Inc ARRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-586,743
| Closed | -$27.2M | – | 4665 |
|
|
2019
Q2 | $27.2M | Buy |
586,743
+476,329
| +431% | +$22.1M | 0.02% | 505 |
|
|
2019
Q1 | $2.69M | Buy |
110,414
+87,859
| +390% | +$2.14M | ﹤0.01% | 1358 |
|
|
2018
Q4 | $322K | Sell |
22,555
-81,415
| -78% | -$1.16M | ﹤0.01% | 2507 |
|
|
2018
Q3 | $1.58M | Buy |
103,970
+75,307
| +263% | +$1.15M | ﹤0.01% | 1957 |
|
|
2018
Q2 | $481K | Sell |
28,663
-91,425
| -76% | -$1.53M | ﹤0.01% | 2302 |
|
|
2018
Q1 | $1.96M | Sell |
120,088
-399,624
| -77% | -$6.52M | ﹤0.01% | 1382 |
|
|
2017
Q4 | $6.65M | Sell |
519,712
-290,376
| -36% | -$3.72M | 0.01% | 778 |
|
|
2017
Q3 | $9.97M | Buy |
810,088
+682,602
| +535% | +$8.4M | 0.01% | 574 |
|
|
2017
Q2 | $1.07M | Sell |
127,486
-377,030
| -75% | -$3.16M | ﹤0.01% | 1529 |
|
|
2017
Q1 | $4.51M | Buy |
504,516
+439,914
| +681% | +$3.93M | ﹤0.01% | 814 |
|
|
2016
Q4 | $567K | Buy |
64,602
+61,699
| +2,125% | +$542K | ﹤0.01% | 1775 |
|
|
2016
Q3 | $19K | Buy |
+2,903
| New | +$19K | ﹤0.01% | 3065 |
|
|
2016
Q2 | – | Sell |
-12,905
| Closed | -$26K | – | 4001 |
|
|
2016
Q1 | $26K | Sell |
12,905
-53,210
| -80% | -$107K | ﹤0.01% | 2726 |
|
|
2015
Q4 | $265K | Sell |
66,115
-76,401
| -54% | -$306K | ﹤0.01% | 1925 |
|
|
2015
Q3 | $570K | Sell |
142,516
-229,122
| -62% | -$916K | ﹤0.01% | 1672 |
|
|
2015
Q2 | $2.6M | Buy |
371,638
+158,049
| +74% | +$1.11M | ﹤0.01% | 1065 |
|
|
2015
Q1 | $1.5M | Buy |
213,589
+6,748
| +3% | +$47.2K | ﹤0.01% | 1402 |
|
|
2014
Q4 | $829K | Buy |
206,841
+189,580
| +1,098% | +$760K | ﹤0.01% | 1719 |
|
|
2014
Q3 | $53K | Sell |
17,261
-8,027
| -32% | -$24.6K | ﹤0.01% | 2977 |
|
|
2014
Q2 | $102K | Buy |
25,288
+6,101
| +32% | +$24.6K | ﹤0.01% | 2713 |
|
|
2014
Q1 | $77K | Sell |
19,187
-2,488
| -11% | -$9.99K | ﹤0.01% | 2926 |
|
|
2013
Q4 | $109K | Sell |
21,675
-8,535
| -28% | -$42.9K | ﹤0.01% | 2999 |
|
|
2013
Q3 | $182K | Buy |
30,210
+9,676
| +47% | +$58.3K | ﹤0.01% | 2664 |
|
|
2013
Q2 | $93K | Buy |
+20,534
| New | +$93K | ﹤0.01% | 3063 |
|